# Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

> **NCT02087566** · NA · COMPLETED · sponsor: **Damanhour University** · enrollment: 18 (actual)

## Conditions studied

- Renal Failure
- Impaired Renal Function

## Interventions

- **DRUG:** 600 mg linezolid

## Key facts

- **NCT ID:** NCT02087566
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02087566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02087566, "Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02087566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
